:A Randomized Trial Comparing CD3/CD19 Depleted or CD3 D

  • Cooley, Sarah A, (PI)

Project: Research project

Description

:A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Consolidation Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts
StatusActive
Effective start/end date7/1/157/30/20

Funding

  • MILTENYI BIOTEC, INC.

Fingerprint

Acute Myeloid Leukemia
Natural Killer Cells
Therapeutics